The emerging role of the CTLA-4 gene in autoimmune endocrinopathies

in European Journal of Endocrinology
Authors:
B VaidyaDepartment of Diabetes, Endocrinology and Vascular Medicine, Peninsula Medical School, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK. bvaidya@hgmp.mrc.ac.uk

Search for other papers by B Vaidya in
Current site
Google Scholar
PubMed
Close
and
S PearceDepartment of Diabetes, Endocrinology and Vascular Medicine, Peninsula Medical School, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK. bvaidya@hgmp.mrc.ac.uk

Search for other papers by S Pearce in
Current site
Google Scholar
PubMed
Close
View More View Less
Free access

It is thought that the majority of autoimmune endocrinopathies, including Graves' disease, autoimmune hypothyroidism, type 1 diabetes mellitus and autoimmune Addison's disease (sporadic and as well as autoimmune polyendocrinopathy syndrome type 2) are inherited as complex genetic traits. Multiple genetic and environmental factors interact with each other to confer susceptibility to these disorders. In recent years there have been considerable efforts towards defining susceptibility genes for complex traits. These investigations have shown, with increasing evidence, that the cytotoxic T lymphocyte antigen-4 (CTLA-4) gene is an important susceptibility locus for autoimmune endocrinopathies and other autoimmune disorders. Here we review the genetic and functional analyses of the CTLA-4 locus in autoimmune endocrinopathies, and discuss the recent efforts in fine-mapping this locus.

 

  • Collapse
  • Expand

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 441 425 3
PDF Downloads 128 123 4